Frank Parrado - Sharps Technology Corporate Controller

STSS Stock  USD 6.72  0.36  5.66%   

Executive

Frank Parrado is Corporate Controller of Sharps Technology
Address 105 Maxess Road, Melville, NY, United States, 11747
Phone631-574-4436
Webhttps://sharpstechnology.com

Sharps Technology Management Efficiency

The company has return on total asset (ROA) of (0.5038) % which means that it has lost $0.5038 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0665) %, meaning that it created substantial loss on money invested by shareholders. Sharps Technology's management efficiency ratios could be used to measure how well Sharps Technology manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.34 in 2025. Return On Capital Employed is likely to drop to -4.75 in 2025. At this time, Sharps Technology's Non Currrent Assets Other are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 356.7 K in 2025, whereas Non Current Assets Total are likely to drop slightly above 3.7 M in 2025.
Sharps Technology currently holds 3.76 M in liabilities with Debt to Equity (D/E) ratio of 0.56, which is about average as compared to similar companies. Sharps Technology has a current ratio of 2.59, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Sharps Technology's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 13 records

EXECUTIVE Age

Pamela MBAPredictive Oncology
49
Peter WulffGlucoTrack
66
Joshua MBAPredictive Oncology
52
Paul GoodeGlucoTrack
57
James CardwellGlucoTrack
64
Gregory CPAAclarion
59
Rika HozumiHeartCore Enterprises
N/A
Joseph McGuireNexgel Inc
67
Gregory RobbNexgel Inc
N/A
Mark TapsakGlucoTrack
56
Vincent WongGlucoTrack
N/A
James ThrowerGlucoTrack
55
Drinda BenjaminGlucoTrack
49
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. The company was incorporated in 2017 and is based in Melville, New York. Sharps Technology operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 3 people. Sharps Technology (STSS) is traded on NASDAQ Exchange in USA. It is located in 105 Maxess Road, Melville, NY, United States, 11747 and employs 55 people. Sharps Technology is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Sharps Technology Leadership Team

Elected by the shareholders, the Sharps Technology's board of directors comprises two types of representatives: Sharps Technology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sharps. The board's role is to monitor Sharps Technology's management team and ensure that shareholders' interests are well served. Sharps Technology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sharps Technology's outside directors are responsible for providing unbiased perspectives on the board's policies.
Paul III, Executive Chairman
Adam Holdsworth, Managing Director
Robert Hayes, CEO Director
Yuwen Zhang, Chief Director
Alan Blackman, Chief CoChairman
Steven MD, Chief Officer
Ben Scheu, Senior Sales
Frank Parrado, Corporate Controller
Barry Berler, Chief Inventor
Andrew CPA, Chief Officer

Sharps Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sharps Technology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Sharps Stock Analysis

When running Sharps Technology's price analysis, check to measure Sharps Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sharps Technology is operating at the current time. Most of Sharps Technology's value examination focuses on studying past and present price action to predict the probability of Sharps Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sharps Technology's price. Additionally, you may evaluate how the addition of Sharps Technology to your portfolios can decrease your overall portfolio volatility.